Inhaled Corticosteroid-Long-Acting Beta-2 Agonist Fixed-Dose Combinations: Preferred Controller in 6- to 11-Year-Olds with Persistent Asthma
ICS-LABA fixed-dose combination therapies have been found to be more effective than ICS monotherapy in preventing asthma exacerbations in 6-11-year-old children with persistent asthma and could be recommended as the preferred controllers.
Authors
- Arzu Bakırtaş (ORCID: https://orcid.org/0000-0002-7694-8944)
- Sinem Polat Terece (ORCID: https://orcid.org/0000-0001-7107-5489)
- Hacer İlbilge Ertoy Karagöl (ORCID: https://orcid.org/0000-0002-8190-062X)
- Gizem Köken (ORCID: https://orcid.org/0000-0001-7972-3436)
- Ceren Varer Akpinar
Institutions
- Giresun University (TR)
- Gazi University (TR)
Publication Details
- Journal
- International Archives of Allergy and Immunology
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1159/000544938
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00